Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Miltefosine in Cutaneous Leishmaniasis
NCT01462500Phase 4Completed
- Sponsor
- CIDEIM
- Start
- Oct 2011
- Primary completion
- May 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of miltefosine in cutaneous leishmaniasis (CL), sponsored by CIDEIM. Started Oct 2011; status: completed.
02
Drugs
miltefosine
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on NCT01462500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01462500.